Motley Rice - Attorneys at Law
Navigation
Main navigation
Motley Rice represents clients across many areas.
Learn about the cases Motley Rice is actively representing clients in or cases that we've litigated previously.
People have filed lawsuits against weight loss drug manufacturers Novo Nordisk and Eli Lilly.
Lawsuits allege talcum powder use is linked to reproductive organ cancer for women.
Individuals who know of an FCA violation can file a qui tam whistleblower lawsuit.
Social media companies are being sued over alleged teenage mental health harms.
This library contains more than 2,000 exhibits cited in social media harm lawsuits across the United States.
Survivors of sexual abuse may hire a civil sexual abuse attorney to discuss what they’ve experienced and look into pursuing legal action.
Studies link hair relaxers to uterine/ovarian cancer. Lawsuits seek to hold companies accountable.
Asbestos-related diseases include mesothelioma, lung cancer and asbestosis.
ERISA sets minimum standards including which employees are eligible for benefits, how benefits must be calculated, and when benefits vest.
While litigation can take years to complete from start to finish, our firm is always working for our clients, no matter how long it takes or how hard it gets.
Motley Rice attorneys and support personnel are dedicated to representing clients and working with co-counsel located throughout the United States and around the world.
Comprehensive, up-to-date news on the issues surrounding the litigation areas of Motley Rice LLC.
Learn about the latest happenings from lawsuits and other events impacting plaintiffs, including the new Social Media Harm Evidence Library.
Read news coverage about Motley Rice, its clients and our efforts to hold defendants accountable.
Motley Rice lawyers share their insights on litigation and more to inform people exploring their legal options.
This case is no longer active
The Legal Team
Motley Rice fights on behalf of shareholders to enforce corporate fiduciaries’ duties of care, loyalty and candor. These duties require corporate directors to disclose—fully, fairly and accurately—all material facts when seeking shareholder approval of the sale of a company.
In May 2010, the Delaware Court of Chancery held that the private-equity buyout of PLATO Learning, Inc., an educational software company, by Thoma Bravo, LLC, a private equity fund, should be preliminarily enjoined because the proxy statement issued ahead of the shareholder vote contained misleading information and omitted material information important to the shareholders’ decision as to whether to approve the merger. In rendering its decision, the court addressed three different disclosure issues:
The court ruled that the preliminary injunction would be lifted after “timely and satisfactory disclosures are made in a way that gives the PLATO stockholders adequate opportunity to digest them before a final merger vote.”
To date, the published decision of this precedent-setting case has been cited in more than a dozen state, federal and appellate court opinions and orders; in hundreds of trial and appellate court briefs and numerous law review articles.
Motley Rice served as sole class counsel in this case, Maric Capital Master Fund, Ltd. v. PLATO Learning, Inc., 11 A.3d 1175 (Del. Ch. 2010).
If you have questions regarding cases similar to Maric Capital Master Fund, Ltd. v. PLATO Learning, Inc. or if you would like to discuss a potential case, contact securities attorney Bill Norton by email or call 1.800.768.4026.
*Prior results do not guarantee a similar outcome.